purchase customization

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Opioid Induced Constipation Drugs
1.2 Key Market Segments
1.2.1 Opioid Induced Constipation Drugs Segment by Type
1.2.2 Opioid Induced Constipation Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Opioid Induced Constipation Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Opioid Induced Constipation Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Opioid Induced Constipation Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Opioid Induced Constipation Drugs Market Competitive Landscape
3.1 Global Opioid Induced Constipation Drugs Sales by Manufacturers (2019-2024)
3.2 Global Opioid Induced Constipation Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Opioid Induced Constipation Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Opioid Induced Constipation Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Opioid Induced Constipation Drugs Sales Sites, Area Served, Product Type
3.6 Opioid Induced Constipation Drugs Market Competitive Situation and Trends
3.6.1 Opioid Induced Constipation Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Opioid Induced Constipation Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Opioid Induced Constipation Drugs Industry Chain Analysis
4.1 Opioid Induced Constipation Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Opioid Induced Constipation Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Opioid Induced Constipation Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Opioid Induced Constipation Drugs Sales Market Share by Type (2019-2024)
6.3 Global Opioid Induced Constipation Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Opioid Induced Constipation Drugs Price by Type (2019-2024)
7 Opioid Induced Constipation Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Opioid Induced Constipation Drugs Market Sales by Application (2019-2024)
7.3 Global Opioid Induced Constipation Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Opioid Induced Constipation Drugs Sales Growth Rate by Application (2019-2024)
8 Opioid Induced Constipation Drugs Market Segmentation by Region
8.1 Global Opioid Induced Constipation Drugs Sales by Region
8.1.1 Global Opioid Induced Constipation Drugs Sales by Region
8.1.2 Global Opioid Induced Constipation Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Opioid Induced Constipation Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Opioid Induced Constipation Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Opioid Induced Constipation Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Opioid Induced Constipation Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Opioid Induced Constipation Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Ironwood Pharmaceuticals Inc
9.1.1 Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Basic Information
9.1.2 Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Product Overview
9.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Product Market Performance
9.1.4 Ironwood Pharmaceuticals Inc Business Overview
9.1.5 Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs SWOT Analysis
9.1.6 Ironwood Pharmaceuticals Inc Recent Developments
9.2 Daiichi Sankyo Co Ltd
9.2.1 Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Basic Information
9.2.2 Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Product Overview
9.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Product Market Performance
9.2.4 Daiichi Sankyo Co Ltd Business Overview
9.2.5 Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs SWOT Analysis
9.2.6 Daiichi Sankyo Co Ltd Recent Developments
9.3 Pfizer
9.3.1 Pfizer Opioid Induced Constipation Drugs Basic Information
9.3.2 Pfizer Opioid Induced Constipation Drugs Product Overview
9.3.3 Pfizer Opioid Induced Constipation Drugs Product Market Performance
9.3.4 Pfizer Opioid Induced Constipation Drugs SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 Progenics Pharmaceuticals Inc
9.4.1 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Basic Information
9.4.2 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Product Overview
9.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Product Market Performance
9.4.4 Progenics Pharmaceuticals Inc Business Overview
9.4.5 Progenics Pharmaceuticals Inc Recent Developments
9.5 Shionogi and Co., Ltd
9.5.1 Shionogi and Co., Ltd Opioid Induced Constipation Drugs Basic Information
9.5.2 Shionogi and Co., Ltd Opioid Induced Constipation Drugs Product Overview
9.5.3 Shionogi and Co., Ltd Opioid Induced Constipation Drugs Product Market Performance
9.5.4 Shionogi and Co., Ltd Business Overview
9.5.5 Shionogi and Co., Ltd Recent Developments
9.6 Allergan Plc
9.6.1 Allergan Plc Opioid Induced Constipation Drugs Basic Information
9.6.2 Allergan Plc Opioid Induced Constipation Drugs Product Overview
9.6.3 Allergan Plc Opioid Induced Constipation Drugs Product Market Performance
9.6.4 Allergan Plc Business Overview
9.6.5 Allergan Plc Recent Developments
9.7 Nektar Therapeutics
9.7.1 Nektar Therapeutics Opioid Induced Constipation Drugs Basic Information
9.7.2 Nektar Therapeutics Opioid Induced Constipation Drugs Product Overview
9.7.3 Nektar Therapeutics Opioid Induced Constipation Drugs Product Market Performance
9.7.4 Nektar Therapeutics Business Overview
9.7.5 Nektar Therapeutics Recent Developments
9.8 Purdue Pharma
9.8.1 Purdue Pharma Opioid Induced Constipation Drugs Basic Information
9.8.2 Purdue Pharma Opioid Induced Constipation Drugs Product Overview
9.8.3 Purdue Pharma Opioid Induced Constipation Drugs Product Market Performance
9.8.4 Purdue Pharma Business Overview
9.8.5 Purdue Pharma Recent Developments
9.9 S.L.A. Pharma AG
9.9.1 S.L.A. Pharma AG Opioid Induced Constipation Drugs Basic Information
9.9.2 S.L.A. Pharma AG Opioid Induced Constipation Drugs Product Overview
9.9.3 S.L.A. Pharma AG Opioid Induced Constipation Drugs Product Market Performance
9.9.4 S.L.A. Pharma AG Business Overview
9.9.5 S.L.A. Pharma AG Recent Developments
9.10 Mundipharma International Limited
9.10.1 Mundipharma International Limited Opioid Induced Constipation Drugs Basic Information
9.10.2 Mundipharma International Limited Opioid Induced Constipation Drugs Product Overview
9.10.3 Mundipharma International Limited Opioid Induced Constipation Drugs Product Market Performance
9.10.4 Mundipharma International Limited Business Overview
9.10.5 Mundipharma International Limited Recent Developments
9.11 Ono Pharmaceutical Co., Ltd
9.11.1 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Basic Information
9.11.2 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Product Overview
9.11.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Product Market Performance
9.11.4 Ono Pharmaceutical Co., Ltd Business Overview
9.11.5 Ono Pharmaceutical Co., Ltd Recent Developments
9.12 Takeda Pharmaceutical Company Limited
9.12.1 Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Basic Information
9.12.2 Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Product Overview
9.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Product Market Performance
9.12.4 Takeda Pharmaceutical Company Limited Business Overview
9.12.5 Takeda Pharmaceutical Company Limited Recent Developments
9.13 Theravance Biopharma Inc
9.13.1 Theravance Biopharma Inc Opioid Induced Constipation Drugs Basic Information
9.13.2 Theravance Biopharma Inc Opioid Induced Constipation Drugs Product Overview
9.13.3 Theravance Biopharma Inc Opioid Induced Constipation Drugs Product Market Performance
9.13.4 Theravance Biopharma Inc Business Overview
9.13.5 Theravance Biopharma Inc Recent Developments
9.14 Bausch Health
9.14.1 Bausch Health Opioid Induced Constipation Drugs Basic Information
9.14.2 Bausch Health Opioid Induced Constipation Drugs Product Overview
9.14.3 Bausch Health Opioid Induced Constipation Drugs Product Market Performance
9.14.4 Bausch Health Business Overview
9.14.5 Bausch Health Recent Developments
9.15 Cosmo Pharmaceuticals SA
9.15.1 Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Basic Information
9.15.2 Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Product Overview
9.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Product Market Performance
9.15.4 Cosmo Pharmaceuticals SA Business Overview
9.15.5 Cosmo Pharmaceuticals SA Recent Developments
9.16 Daewoong Pharmaceutical
9.16.1 Daewoong Pharmaceutical Opioid Induced Constipation Drugs Basic Information
9.16.2 Daewoong Pharmaceutical Opioid Induced Constipation Drugs Product Overview
9.16.3 Daewoong Pharmaceutical Opioid Induced Constipation Drugs Product Market Performance
9.16.4 Daewoong Pharmaceutical Business Overview
9.16.5 Daewoong Pharmaceutical Recent Developments
9.17 C.B. Fleet Company
9.17.1 C.B. Fleet Company Opioid Induced Constipation Drugs Basic Information
9.17.2 C.B. Fleet Company Opioid Induced Constipation Drugs Product Overview
9.17.3 C.B. Fleet Company Opioid Induced Constipation Drugs Product Market Performance
9.17.4 C.B. Fleet Company Business Overview
9.17.5 C.B. Fleet Company Recent Developments
9.18 Sucampo Pharmaceuticals
9.18.1 Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Basic Information
9.18.2 Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Product Overview
9.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Product Market Performance
9.18.4 Sucampo Pharmaceuticals Business Overview
9.18.5 Sucampo Pharmaceuticals Recent Developments
10 Opioid Induced Constipation Drugs Market Forecast by Region
10.1 Global Opioid Induced Constipation Drugs Market Size Forecast
10.2 Global Opioid Induced Constipation Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Opioid Induced Constipation Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Opioid Induced Constipation Drugs Market Size Forecast by Region
10.2.4 South America Opioid Induced Constipation Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Opioid Induced Constipation Drugs by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Opioid Induced Constipation Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Opioid Induced Constipation Drugs by Type (2025-2030)
11.1.2 Global Opioid Induced Constipation Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Opioid Induced Constipation Drugs by Type (2025-2030)
11.2 Global Opioid Induced Constipation Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Opioid Induced Constipation Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Opioid Induced Constipation Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings